The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Since the beginning of the Covid-19 pandemic, there has been a lot of talk about vaccines. We’ve taken a look at what a vaccine actually is and how long it might take until we get one ...

Stocks that topped our screen include the biotechs Biogen, Moderna ... The stock fell dramatically last year, as sales of its Covid-19 vaccine fell well short of expectations, but analysts ...

As the 130+ vaccine candidates currently in development progress through clinical testing, a key question for their manufacturers is how COVID-19 might be changing the equation when it comes to ...

Jan 20 - Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining claims made in a U.S. broadcast that the inoculations have caused a ...

PARIS - A fringe anti-vaccine movement took advantage of the Covid-19 pandemic to bring conspiracy theories to a much wider audience, propelling dangerous misinformation about life-saving jabs ...

This includes more than $3 billion in COVID-19 vaccine sales and minimal sales ... Sage Therapeutics SAGE announced that its partner Biogen made an unsolicited, non-binding proposal offer to ...

You're watching Coronavirus in Context. I'm Dr. John Whyte, chief medical officer at WebMD. There's a lot of talk about vaccines. Some folks are saying it's going to be available by the fall.

where public health workers are no longer allowed to promote certain vaccines, such as the COVID-19, flu and mpox shots, to the public. Why is this occurring and why is it important? The answer is ...

In the latest edition of What HCPs Think, CREATION.co's Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. The formation of blood clots is ...